Tikun Europe, the first pharmaceutical company active in the field of medical cannabis in Greece, has completed the construction of its greenhouse cultivation unit, which is located at the region of Corinth, in Peloponnese. The company will apply for the operations license by the end of March 2022.
With an investment that is expected to exceed €40,000,000, Tikun Europe has created a 56,000m2 state-of-the-art production site, with facilities and equipment of latest technology. The facility has three distinct units: the greenhouse cultivation area, the post-harvest processing area and the area designated for the production and packaging of finished medical cannabis products.
The 21,000m2 greenhouse is the first unit designed to produce medical cannabis in Greece and the site where actual cultivation of medical cannabis plants will take place in the upcoming months. The plants will be used to create Tikun Europe’s innovative and high-quality medical cannabis products. The facility has an annual production capacity of 10 tons of dry flower that can be used for the production of various finished dosage forms. Plans include its possible expansion by 50%, with a subsequent production increase.
Overall, Tikun Europe’s greenhouse and manufacturing facility complies with EU GACP/GMP standards and local legislation for the cultivation and processing of medical cannabis. All process steps are incorporated in the Quality System of the company, ensuring the high product quality and safety. The company is in the process of obtaining all the necessary licenses and certifications and will operate with high responsibility and respect to the environment and the local community.
The cultivation operations are estimated to commence in April 2022. The GMP certification and the initiation of operations of the manufacturing facility is scheduled for June 2022.
Tikun Europe is about to launch a complete range of CBD products; the Tikun CBD range, a Holistic, Natural Balance offering, which is produced in a certified Factory in France.
